Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Herbst, B
Right arrow Articles by Lindemann, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbst, B
Right arrow Articles by Lindemann, A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC- positive Langerhans cell and the interdigitating dendritic cell type

B Herbst, G Kohler, A Mackensen, H Veelken, P Kulmburg, FM Rosenthal, HE Schaefer, R Mertelsmann, P Fisch and A Lindemann

Department of Medicine I (Hematology/Oncology), University Medical Center Freiburg, Germany.

We have demonstrated recently that Birbeck granule-positive Langerhans cells (LC) can be derived from CD34+ peripheral blood progenitor cells in the presence of a seven-cytokine cocktail (CC7-7). Here, we show that the sequential use of early-acting hematopoietic growth factors, stem cell factor, interleukin (IL)-3, and IL-6, followed on day 8 by differentiation in the two-factor combination IL-4 plus granulocytemacrophage colony-stimulating factor (GM-CSF) (CC4GM) is more efficient and allows the cells to be arrested in the LC stage for more than 1 week while continuous maturation occurs in CC7-7. Maturation of LC to interdigitating dendritic cells (DC) could specifically be induced within 60 hours by addition of tumor necrosis factor-alpha (20 ng/mL) or lipopolysaccharide (100 ng/mL). Using LC that had been enriched to greater than 90% CD1a+ cells by an immunoaffinity column, we were able to define clear-cut differences between LC and DC that corroborate data of the respective cells derived from epithelial borders (LC) or from lymph nodes (LN) and spleen (DC). Thus, molecules and functions involved in antigen (AG) uptake and processing were highly expressed in LC, while those involved in AG presentation were at maximum in DC. LC were CD1a+2 DR+2, CD23+, CD36+, CD80-, CD86-, and CD25-, while DC were CD1a+/- DR+3, CD23-, CD36-, CD80+, CD86+2, and CD25+, CD40 and CD32 were moderately expressed and nearly unchanged on maturation, in contrast to monocyte-derived DC. Macropinocytosis of fluorescein isothiocyanate-dextran was dominant in LC, as were multilamellar major histocompatibility complex (MHC) class II compartments (MIICs), which were detected by electron microscopy. The functional dichotomy of these cell types was finally supported by testing the AG-presenting cell function for tetanus toxoid to primed autologous T-cell lines, which was optimal when cells were loaded with AG as LC and subsequently induced to become DC.

Volume 88, Issue 7, pp. 2541-2548, 10/01/1996
Copyright © 1996 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
P. Veron, V. Allo, C. Riviere, J. Bernard, A.-M. Douar, and C. Masurier
Major Subsets of Human Dendritic Cells Are Efficiently Transduced by Self-Complementary Adeno-Associated Virus Vectors 1 and 2
J. Virol., May 15, 2007; 81(10): 5385 - 5394.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
R. Sluyter and J. S. Wiley
Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors
Int. Immunol., December 1, 2002; 14(12): 1415 - 1421.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Ponsaerts, G. Van den Bosch, N. Cools, A. Van Driessche, G. Nijs, M. Lenjou, F. Lardon, C. Van Broeckhoven, D. R. Van Bockstaele, Z. N. Berneman, et al.
Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells
J. Immunol., August 15, 2002; 169(4): 1669 - 1675.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. J. Bontkes, T. D. de Gruijl, G. J. Schuurhuis, R. J. Scheper, C. J. L. M. Meijer, and E. Hooijberg
Expansion of dendritic cell precursors from human CD34+ progenitor cells isolated from healthy donor blood; growth factor combination determines proliferation rate and functional outcome
J. Leukoc. Biol., August 1, 2002; 72(2): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. F. I. Van Tendeloo, P. Ponsaerts, F. Lardon, G. Nijs, M. Lenjou, C. Van Broeckhoven, D. R. Van Bockstaele, and Z. N. Berneman
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells
Blood, July 1, 2001; 98(1): 49 - 56.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. K. Waller, H. Rosenthal, T. W. Jones, J. Peel, S. Lonial, A. Langston, I. Redei, I. Jurickova, and M. W. Boyer
Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation
Blood, May 15, 2001; 97(10): 2948 - 2956.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Oelke, U. Moehrle, J.-L. Chen, D. Behringer, V. Cerundolo, A. Lindemann, and A. Mackensen
Generation and Purification of CD8+ Melan-A-specific Cytotoxic T Lymphocytes for Adoptive Transfer in Tumor Immunotherapy
Clin. Cancer Res., May 1, 2000; 6(5): 1997 - 2005.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Gatti, M. A. Velleca, B. C. Biedermann, W. Ma, J. Unternaehrer, M. W. Ebersold, R. Medzhitov, J. S. Pober, and I. Mellman
Large-Scale Culture and Selective Maturation of Human Langerhans Cells from Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Progenitors
J. Immunol., April 1, 2000; 164(7): 3600 - 3607.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
E. L. NELSON, S. STROBL, J. SUBLESKI, D. PRIETO, W. C. KOPP, and P. J. NELSON
Cycling of human dendritic cell effector phenotypes in response to TNF-{alpha}: modification of the current `maturation' paradigm and implications for in vivo immunoregulation
FASEB J, November 1, 1999; 13(14): 2021 - 2030.
[Abstract] [Full Text]


Home page
BloodHome page
B. Canque, Y. Bakri, S. Camus, M. Yagello, A. Benjouad, and J. C. Gluckman
The Susceptibility to X4 and R5 Human Immunodeficiency Virus-1 Strains of Dendritic Cells Derived In Vitro From CD34+ Hematopoietic Progenitor Cells Is Primarily Determined by Their Maturation Stage
Blood, June 1, 1999; 93(11): 3866 - 3875.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. L. Cavanagh, R. J. Saal, K. L. Grimmett, and R. Thomas
Proliferation in Monocyte-Derived Dendritic Cell Cultures Is Caused by Progenitor Cells Capable of Myeloid Differentiation
Blood, September 1, 1998; 92(5): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Palucka, N. Taquet, F. Sanchez-Chapuis, and J. C. Gluckman
Dendritic Cells as the Terminal Stage of Monocyte Differentiation
J. Immunol., May 1, 1998; 160(9): 4587 - 4595.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Schuler and R.M. Steinman
Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors
J. Exp. Med., October 20, 1997; 186(8): 1183 - 1187.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1996 by American Society of Hematology         Online ISSN: 1528-0020